Article
Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network
2020-02-20
Abstract excerpt
<h4>ABSTRACT</h4> Mechanisms-of-resistance to decitabine and 5-azacytidine, mainstay treatments for myeloid malignancies, require investigation and countermeasures. Both are nucleoside analog pro-drugs processed by pyrimidine metabolism into a nucleotide analog that depletes the key epigenetic regulator DNA methyltranseferase 1 (DNMT1). We report here that DNMT1 protein, although substantially depleted (~50%) in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b12aa87b-c45c-5852-a08e-dbde61d77254
- DOI
- 10.1101/2020.02.20.958405
